Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Completed

Effects of FT011 in Systemic Sclerosis

NCT04647890

Conditions
Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Systemic, +3 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • Certa SSc trial site Nijmegen, Netherlands
  • Certa SSc trial site Bydgoszcz, Poland
View Trial Details
Completed

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

NCT02503644

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski Pleven, Bulgaria
  • Multiprofile Hospital for Active Treatment Plovdiv Plovdiv, Bulgaria
  • University Multiprofile Hospital for Active Treatment -Kaspela Plovdiv, Bulgaria
  • University Multiprofile Hospital for Active Treatment - "Sveti Ivan Rilski" Sofia, Bulgaria
View all 49 locations
View Trial Details
Active, Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details

Related conditions